Get the latest news, insights, and market updates on DOCS (Doximity, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
1 Profitable Stock with Impressive Fundamentals and 2 We Brush Off
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity". Dec 29, 2025 - $DOCS
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More
Pre-Market Stock Futures: The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened one once again. The major indices all finished the session modestly lower on Friday, with the venerable S&P 500 taking early bows as it hit a fresh all-time high, joining the Dow Jones Industrial Average ... Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More Dec 29, 2025 - $DOCS
Why BofA Sees Strong Upside for Doximity (DOCS)
Doximity (NYSE:DOCS) is one of the most promising mid-cap healthcare stocks under $50. On December 16, Bank of America analyst Allen Lutz reiterated his bullish stance on Doximity (NYSE:DOCS). He assigned a Buy rating to the stock with a $82 price target. This implies a highly attractive 88% upside potential for investors within the prevailing […] Dec 22, 2025 - $DOCS
Doximity (DOCS) Stock Trades Up, Here Is Why
Shares of medical professional network Doximity (NYSE:DOCS) jumped 3.3% in the afternoon session after the stock's positive momentum continued as a Bank of America analyst reiterated a Buy rating and an $82 price target on the stock. Dec 22, 2025 - $DOCS
3 Growth Stocks with Explosive Upside
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. Dec 18, 2025 - $DOCS
How Analyst Upgrades Highlighting AI Tools And Ad Shift Potential At Doximity (DOCS) Has Changed Its Investment Story
Earlier this month, Morgan Stanley and Raymond James upgraded Doximity after highlighting its strong free cash flow, balance sheet strength, and expanded AI-enabled workflow tools that are increasingly embedded in clinicians’ daily routines. Analysts also pointed to potential benefits from tighter rules on direct-to-consumer drug advertising, which could steer more pharmaceutical marketing budgets toward Doximity’s physician-focused platform. Now we’ll examine how this renewed focus on... Dec 18, 2025 - $DOCS
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple